(Q38720418)

English

Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group

scientific article published on 2 February 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

1 reference

Europe PubMed Central

Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

drug interaction

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

Ana Ruiz-Garcia

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Mats O Karlsson

7

object named as

Mats O Karlsson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Peter L Bonate

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Malidi Ahamadi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Nageshwar Budha

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Amparo de la Peña

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Justin C Earp

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ying Hong

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Patanjali Ravva

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Herbert Struemper

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

2 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

5 September 2017

Journal of Pharmacokinetics and Pharmacodynamics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

123-135

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Utility of population pharmacokinetic modeling in the assessment of therapeutic protein-drug interactions.

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Estimation of population pharmacokinetic parameters in the presence of non-compliance

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

The impact of compliance in pharmacokinetic studies.

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Dealing with the complex drug-drug interactions: towards mechanistic models.

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

A useful tool for drug interaction evaluation: the University of Washington Metabolism and Transport Drug Interaction Database

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Semi-mechanistic population pharmacokinetic drug-drug interaction modelling of a long half-life substrate and itraconazole

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

A semiphysiological population pharmacokinetic model for dynamic inhibition of liver and gut wall cytochrome P450 3A by voriconazole

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir, and saquinavir after simultaneous and staggered oral administration

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

An evaluation of population pharmacokinetics in therapeutic trials. Part II. Detection of a drug-drug interaction

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Covariate selection in pharmacometric analyses: a review of methods

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Assessing the efficiency of mixed effects modelling in quantifying metabolism based drug-drug interactions: using in vitro data as an aid to assess study power

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Design evaluation for a population pharmacokinetic study using clinical trial simulations: a case study.

1 reference

https://api.crossref.org/works/10.1007%2FS10928-016-9464-2

21 January 2018

Power estimation using a population pharmacokinetics model with optimal design by clinical trial simulations: application in pharmacokinetic drug-drug interaction studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/26837775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics of trastuzumab in patients with HER2+ metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26837775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics/toxicodynamics (PK/TD) relationship of SAM486A in phase I studies in patients with advanced cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/26837775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/26837775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and power of a population pharmacokinetic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26837775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26837775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10928-016-9464-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26837775%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38720418&oldid=2202008880"